MyFinsight
Home
About
Contact
Back
Income Statement
ZyVersa Therapeutics, Inc. (ZVSA)
source: myfinsight.com
Download
Download image
Net loss
-$2,211,317
Pre-tax net loss
-$2,211,317
Interest expense
-$130,036
Loss from operations
-$2,044,132
Change in fair value of
equity payable
$37,149
Total operating
expenses
$2,044,132
General and
administrative
$1,634,195
Research and development
$409,937
Back